AlphaYouKC
Congress trade
Rep. Katherine Clark (D-MA) bought $1K-$15K of Abbott laboratories (ABT) stock
Katherine Clark, U.S. Representative (D-MA), disclosed a purchase of Abbott laboratories (ABT) stock worth $1K-$15K in a STOCK Act filing on Dec 3, 2020.
The trade happened on Oct 22, 2020, 42 days before it was made public.
ABT has moved -10.9% since the trade date, from $109.48 to $97.50 (Oct 2, 2026 close).
- Traded
- Oct 22, 2020
- Disclosed
- Dec 3, 2020
- Filing delay
- 42 days
- Price since
- -10.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (49)
- SellAAPL$1K-$15KDec 3, 2020
- SellAAPL$1K-$15KDec 3, 2020
- BuyABT$1K-$15KDec 3, 2020
- SellBMY$1K-$15KDec 3, 2020
- SellBMY$1K-$15KDec 3, 2020
- SellCCEP$1K-$15KDec 3, 2020
- SellCCEP$1K-$15KDec 3, 2020
- BuyCOST$1K-$15KDec 3, 2020
- BuyCOST$1K-$15KDec 3, 2020
- BuyELAN$1K-$15KDec 3, 2020
- BuyELAN$1K-$15KDec 3, 2020
- BuyFIS$1K-$15KDec 3, 2020
- BuyFIS$1K-$15KDec 3, 2020
- BuyFLIR$1K-$15KDec 3, 2020
- BuyFLIR$1K-$15KDec 3, 2020
- SellGOOG$1K-$15KDec 3, 2020
- SellGOOG$1K-$15KDec 3, 2020
- SellGSK$1K-$15KDec 3, 2020
- SellGSK$1K-$15KDec 3, 2020
- SellHD$1K-$15KDec 3, 2020
More ABT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.